Mallory Morales
Financieel Directeur/CFO bij IMMUNEERING CORPORATION
Vermogen: 11 838 $ op 30-04-2024
Profiel
Mallory Morales is currently the Treasurer, Chief Financial & Accounting Officer at Immuneering Corp.
Prior to this, Ms. Morales worked as the Director & Assistant Controller at Immunomedics, Inc. from 2018 to 2020.
Before that, Ms. Morales held the position of Director-Finance & Global Brand Controller at L'Oréal SA from 2014 to 2018.
Ms. Morales also worked as a Strategic Finance Business Partner at Gilead Sciences, Inc. from 2020 to 2021.
Ms. Morales obtained an undergraduate degree from the State University of New York at Albany.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-03-2024 | 8 278 ( 0.03% ) | 11 838 $ | 30-04-2024 |
Actieve functies van Mallory Morales
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNEERING CORPORATION | Financieel Directeur/CFO | 10-08-2022 |
Eerdere bekende functies van Mallory Morales
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-05-2021 |
| IMMUNOMEDICS, INC. | Directeur/Bestuurslid | 01-10-2020 |
| L'ORÉAL | Financieel Directeur/CFO | 01-04-2018 |
Opleiding van Mallory Morales
| State University of New York at Albany | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| L'ORÉAL | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
